降低风险乳房切除术新术式:先置入假体、后行切除术
本研究探索在降低风险乳房切除术之前先行乳房下皱襞切口双平面置入固定体积硅胶假体的可行性,数月后行切除术并保留假体。8例患者15侧乳房均实现假体完整覆盖,无并发症且美学效果良好,提示该两阶段术式可避免使用组织扩张器和脱细胞真皮基质。
要点
- 先行假体置入再行降低风险乳房切除术在8例15侧乳房中可行且无并发症
- 该术式可避免系列门诊扩张和脱细胞真皮基质的使用
- 假体平均体积433 ml(范围290至545 ml),均实现完整覆盖
核心结论
- 先行置入假体、后续行降低风险乳房切除术并保留假体的两阶段术式可行,无并发症且美学效果良好。
研究设计与样本
- 前瞻性概念验证研究,纳入计划行降低风险乳房切除术的患者,先行双平面置入固定体积硅胶假体,数月后行切除术。
- 共8例患者、15侧手术乳房。
主要发现
- 所有患者均使用解剖型假体并实现每个假体的完整覆盖。
- 假体平均体积433 ml(范围290至545 ml)。
- 无并发症发生,美学效果良好。
关键数值与推荐
- 假体经乳房下皱襞切口行双平面置入。
- 降低风险乳房切除术在数月后作为第二手术进行,假体保留原位并由肌肉和包膜囊保护。
- 乳头根据患者选择予以保留或重建。
临床怎么用
- 对于高风险乳腺癌女性,可考虑先行假体置入再行降低风险乳房切除术,以减少组织扩张器和脱细胞真皮基质的使用及相关问题。
局限性
- 证据等级为治疗性IV级,样本量小(8例15侧乳房),属概念验证研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Risk-reducing mastectomy with tissue expander and then implant-based breast reconstruction conventionally involved immediate submuscular placement of tissue expanders during mastectomy and then, after expansion, replacement of expanders for permanent implants in a second-stage operation. Use of acellular dermal matrix can achieve a single-stage operation; however, acellular dermal matrices are costly and may have potential complications. The authors aim to assess the feasibility of placement of implants as a first-stage procedure before risk-reducing mastectomy as a novel technique of reconstruction that avoids the need for serial outpatient expansion and acellular dermal matrix. METHODS: Patients for whom risk-reducing mastectomy was planned were offered first-stage dual-plane placement of fixed volume silicone gel permanent implants by means of inframammary fold incisions. Risk-reducing mastectomy was undertaken several months later as the second operation, leaving the implants in place protected by the muscle and capsule pocket. Nipples were preserved or reconstructed according to the patient's choice. RESULTS: Eight patients with 15 operated breasts were recruited. Anatomically shaped implants were used in all patients, and complete coverage of each implant was achieved. Mean implant volume was 433 ml (range, 290 to 545 ml). There were no complications, and good aesthetic outcomes were achieved. CONCLUSIONS: This proof-of-principle study finds that placement of implants before risk-reducing mastectomy is a novel technique for women at high breast cancer risk that could reduce the use of tissue expanders and acellular dermal matrices and their associated problems. Two-stage risk-reducing mastectomy with first-stage implant placement and subsequent risk-reducing mastectomy leaving the implants in place is feasible, with no complications, and can produce a good cosmetic outcome. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Lim GH, Baildam AD. Novel Approach for Risk-Reducing Mastectomy: First-Stage Implant Placement and Subsequent Second-Stage Mastectomy. Plast Reconstr Surg. 2018. PMID: 29878997. doi:10.1097/PRS.0000000000004635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。